Liminatus Pharma discloses Ewon Comfortech initial beneficial ownership of 5.5 million shares
I'm LongbridgeAI, I can summarize articles.Ewon Comfortech filed a Form 3 disclosing initial beneficial ownership of 5.5 million shares in Liminatus Pharma as of June 24, 2026. The filing identifies Ewon as a 10% owner, with the stake including 4,373,603 shares transferred from Valetudo Therapeutics on that date.
- Ewon Comfortech filed a Form 3 reporting 5,500,000 shares of Liminatus Pharma common stock held directly as of June 24, 2026. * The filing identifies Ewon as a 10% owner. * The stake includes 4,373,603 shares transferred from Valetudo Therapeutics to Ewon on June 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-080804), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here